Welcome to the HBOT News Network
Hyperbaric Oxygen Therapy (HBOT) is increasingly appearing in the news and new research as a treatment for a variety of conditions involving inflammation. Use the search or select an article below to keep up to date on the most recent HBOT News.
Recent Hyperbaric Oxygen Therapy (HBOT) News
Excerpt from Military Times, Rep. Greg Murphy.Each year, the United States recognizes September as National Suicide Prevention Month. In 2017 alone, more than 47,000 Americans tragically died from suicide. More than 6,100 of these...
From Treat NowThe Commander John Scott Hannon Veterans Mental Health and Suicide Prevention Bill Unanimously Passed in the Senate. Bipartisan legislation to connect veterans with life-saving care is one step closer to becoming law.As...
Featured in Fortune Magazine:In a world full of acronyms—NASA, scuba, and, yes, COVID, among others—it may seem imponderable that one of the most well-known has gone largely unmentioned during discussions of the novel coronavirus. I...
“On Saturday I heard another compelling story from a North Dakota veteran named AJ about the powerful difference Hyperbaric Oxygen Therapy can make in the lives of our veterans. Our legislation advances the study of this impactful...
As a New York University medical researcher who works once a week in an emergency room, Dr. David Lee had the luxury of time to think like a scientist while also treating coronavirus patients whose lungs kept giving out. In every case,...
Article by Dick Clark on National Baromedical ServicesOn May 15, I submitted an Emergency Use Authorization request, seeking FDA approval for hyperbaric oxygen (HBO) treatment of COVID-19 disease. You can read the entire submission in a...
The Undersea Hyperbaric Medical Society (UHMS) has just reconsidered its original opinion on the use of Hyperbaric Oxygen Therapy to treat patients with COVID-19. They now support the compassionate care use of HBOT for COVID-19 in their...
Article by Joel Goldstein on BrainlineThe theory of neural plasticity claims that long after a brain is injured it may still retain the ability to repair itself, to regain lost functions by establishing new neural pathways in response...
Hyperbaric Oxygen Therapy (HBOT) has been used for many decades to treat a variety of maladies which have as their common denominator low tissue oxygen levels (hypoxia). Thanks to the pioneering work of Steve Thom and others, HBOT has...
Recent Hyperbaric Oxygen Therapy (HBOT) Research
Amir Hadanny, MD and Shai Efrati, MD of The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center (the largest hyperbaric treatment center worldwide) in Be'er Ya'akov, Israel has begun a new clinical trial to study...
New Clinical Trial: Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) (OHB10cov)
Jean-Eric Blatteau, MD, PhD of Sainte Anne Military Teaching Hospital in Toulon, France has begun a new clinical trial to study the treatment of COVID-19 patients using Hyperbaric Oxygen Therapy. Several patients with hypoxaemic...
New Clinical Trial: Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection
Dr. Jeffery S Kuo is the Lead Investigator of the latest clinical trial studying the treatment of COVID-19 patients with Hyperbaric Oxygen Therapy. The study will be based out of Ochsner Medical Center in New Orleans, Louisiana....
April 2, 2020, Dr. David Lee posted a new clinical trial on the NIH Clinical Trials website to study the use of Hyperbaric Oxygen Therapy (HBOT) to treat COVID-10. The study is listed as "Not Recruiting Yet," but has an estimated completion date...
Clinical Trial – Pseudoephedrine Prophylaxis for Prevention of Middle Ear Barotrauma in Hyperbaric Oxygen Therapy
Hyperbaric oxygen therapy (HBOT) utilizes 100% oxygen delivery at a pressure greater than 1 atm for the treatment of various emergent medical conditions including carbon monoxide poisoning. The most commonly associated complication of HBOT is middle ear barotrauma (MEB) which occurs when the eustachian tube does not allow air to enter the middle ear space to equalize the pressure between the ambient environment and the inner ear. Patients experiencing MEB usually feel pressure or pain in their ear(s). The spectrum of symptoms ranges from sensation of ear fullness and muffled hearing to severe pain, vertigo and tympanic membrane rupture. HBOT has not been studied. The investigators plan to perform a randomized double blind placebo control trial to determine if pseudoephedrine is effective in decreasing the rate of MEB during HBOT.
COVID-19 may cause severe pneumonitis that require ventilatory support in some patients, the ICU mortality is as high as 62%. Hospitals do not have enough ICU beds to handle the demand and to date there is no effective cure. We explore a treatment administered in a randomized clinical trial that could prevent ICU admission and reduce mortality. The overall hypothesis to be evaluated is that HBO reduce mortality, increase hypoxia tolerance and prevent organ failure in patients with COVID19 pneumonitis by attenuating the inflammatory response.
Clinical Trial – Effect of Self-acupressure on Middle Ear Barotrauma Associated With Hyperbaric Oxygen Therapy
Middle ear barotrauma (MEB) is the most common complication during hyperbaric oxygen therapy
(HBOT). Though Valsalva and Toynbee maneuvers have been proposed to prevent MEB, still some
patients discontinue HBOT due to severe otalgia, hemorrhage or perforation of tympanic
membrane associated with HBOT. Currently, there is no optimal prophylactic management for MEB
associated with HBOT. The aim of this protocol is to investigate the efficacy of
self-acupressure therapy on MEB associated with HBOT.
Hyperbaric oxygen therapy for mild traumatic brain injury persistent postconcussion syndrome: a randomized controlled trial
Abstract: Persistent postconcussion syndrome (PPCS) after mild traumatic brain injury (mTBI) is a significant public health and military problem for which there is limited treatment evidence. The aim of this study was to determine whether forty 150...
Currently, Hyperbaric Oxigen (HBO) is a widely used treatment for several conditions. There
are 14 indications for HBO, officially recognized by the Undersea and Hyperbaric Medical
Society (UHMS), but research is discovering other interesting applications.
HBO plays an important role in enhancing antioxidant defense mechanisms by increasing radical
oxygen species (ROS) and nitric oxide species (NOS). This controlled oxidative stress has
been shown to stop the vicious circle of inflammation – damage – hypoxia already seen in
several diseases. Increased neoangiogenesis has been demonstrated at pressures of 2
atmospheres absolute (ATA), while effects helping ischemic tissues need pressures between 2.5
and 2.8 ATA to develop.
During sports activities, metabolism generates waste products – mostly CO2, lactic acid, but
also ROS. HBO could be useful in modulating antioxidant mechanisms and helping cells in the
recovery after training and sportive competitions.
The authors hypothesize that:
1. HBO can reduce oxidative stress in healthy professional athletes
2. HBO can ameliorate the lactic acid clearance after a maximal exercise
3. HBO at low pressures (L-HBO at 1.45 ATA) is at least comparable to conventional HBO (at
2.5 ATA) in reducing oxidative stress and ameliorating lactic acid clearance after a
The Authors will include healthy athletes. These will be randomly assigned to a control
group, a L-HBO group, or a HBO group. The Authors will assess oxidative stress changes and
lactic acid clearance (testing it after a maximal exercise) before and after 20 L-HBO/HBO
treatments, and after 2 months after the end of treatments.